Author: Anna Forrester|| Date Published: February 9, 2016
Chris Freer
Chris Freer, formerly vice president of population health at SPH Analytics, has been appointed as VP of sales at the health business group of Leidos (NYSE: LDOS).
Leidos said Monday Freer will manage the company’s health group sales strategies, plans and activities to further develop its sales operations, organizational structure and commercial health revenue.
Prior to his work at SPH Analytics, Freer had senior-level positions at Healthgrades and GE Healthcare™s Centricity, global cardiology health information technology and global ultrasound businesses.
“He is a great asset to the Leidos Health team and will help drive growth and market expansion of the complete services life cycle in healthcare IT we provide for our customers, ” said Tom Aikens, deputy health group president at Leidos.
The Space Development Agency has awarded $3.5 billion in other transaction authority agreements to Lockheed Martin, L3Harris Technologies, Northrop Grumman…
The Defense Health Agency has awarded TriWest Healthcare Alliance $6.8 billion to continue providing healthcare and administrative services in support…
HawkEye 360, provider of space-based signals intelligence, has acquired Innovative Signal Analysis, a Dallas, Texas-based company manufacturing high-performance signal-processing technologies.…
